This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds.
Flo Health raises $200 million in Series C funding
London-based Flo Health is a women’s health app that offers period and ovulation tracking, tailored health insights, visual content and a private community for asking questions. The app also has a feature called Flo for Partners, which allows users to educate their partners on their menstrual and reproductive health.
The $200 million investment was from General Atlantic. The funding “will help position Flo for its next phase of growth, with a focus on expanding into new user segments including perimenopause and menopause, enhancing its tech-driven health insights, and pursuing strategic expansion opportunities,” according to the announcement. The company’s valuation is now beyond $1 billion.
HarmonyCares pulls in $200 million
Troy, Michigan-based HarmonyCares is a value-based provider of home-based primary care services. It particularly focuses on high-risk patients. The company has home-based primary care practices across 15 states.
Its $200 million funding round was led by General Catalyst, McKesson Ventures and a “large national payor.” The round also included participation from K2 HealthVentures, Rubicon Founders, Valtruis, HLM Capital and Oak HC/FT. The funding will help the company expand to additional markets and build new technologies to improve clinical outcomes and patient satisfaction.
Spring Health rakes in $100 million in Series E funding
New York City-based Spring Health is a mental health company for employers and health plans. It offers meditation, coaching, therapy, medication and other services. Its Precision Mental Healthcare offering analyzes data on patients’ symptoms and socio-demographic information to determine the best care plan for each patient.
The $100 million Series E funding round was led by Generation Investment Management and included participation from Kinnevik, William K Warren Foundation, RRE and Northzone. It brings Spring Health’s valuation to $3.3 billion. The funding will support product and technology development and help the company expand to new audiences.
Headway raises $100 million in Series D funding
New York City-based Headway helps mental health clinicians accept patients through insurance by supporting them with credentialing, onboarding, clinical training, scheduling, billing and other services. On Headway’s platform, patients can search for mental health providers by location, concern and insurance carrier, and schedule an appointment within 48 hours.
The $100 million Series D funding round was led by Spark Capital and included participation from Thrive Capital, Accel, a16z and Forerunner Ventures. The round brings the company’s valuation to $2.3 billion. Headway is using the funding for its expansion into Medicare Advantage and Medicaid.
Thyme Care secures $95 million in Series C funding
Nashville, Tennessee-based Thyme Care works with health plans, employers and risk-bearing providers across 31 states to support patients fighting cancer. It provides care navigation services, technology and data insights and therapeutic interventions. The company also helps patients understand their diagnosis, find a cancer doctor and receive clinical care between appointments.
The $95 million capital raise includes $55 million in equity funding from Concord Health Partners, CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital. Banc of California is providing $40 million in debt financing. The funding will help Thyme Care grow its business by adding more partnerships with risk-bearing entities.
Photo: Abscent84, Getty Images